Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …

Research on biomarker-driven therapy and immune check-point blockade in non-small cell
lung cancer (NSCLC) is rapidly evolving. The width and depth of clinical trials have also …

Purpose: Clinical patterns and the associated optimal management of acquired resistance to
PD-(L) 1 blockade are poorly understood. Experimental Design: All cases of metastatic lung …

Evidence from a few small randomized trials and retrospective cohorts mostly including
various tumor entities indicates a prolongation of disease free survival (DFS) and overall …

Metastatic non–small cell lung cancer (NSCLC) is highly heterogeneous, and there are
patients with limited areas of metastases (oligometastases) or progression …

Purpose The role of local consolidative therapy (LCT) for metastatic cancers most likely
varies by the particular cancer type. We therefore performed a systematic review with a …

Simple Summary Stereotactic radiation therapy (SBRT) is a type of radiation therapy in
which a small number of high doses of radiation are delivered to a target volume using …

Oligoprogression in non-small cell lung cancer: a narrative review - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …

The breakthrough of a limited number of clones while on immune checkpoint inhibitors
(ICIs), known as oligoprogression, has been previously described. The benefit of ablative …

Background We report the results of an international multi‐institutional cohort of
oligometastatic (OMD) head and neck cancer (HNC) patients treated with SBRT. Methods …